Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Cingulate Inc. before investing.

In this article, we go over a few key elements for understanding Cingulate Inc.’s stock price such as:

• Cingulate Inc.’s current stock price and volume
• Why Cingulate Inc.’s stock price changed recently
• Upgrades and downgrades for CING from analysts
• CING’s stock price momentum as measured by its relative strength

About Cingulate Inc. (CING)

Before we jump into Cingulate Inc.’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

Cingulate Inc., a biopharmaceutical company, develops pharmaceutical products using its drug delivery platform technology for the treatment of attention deficit/hyperactivity disorder (ADHD) and anxiety in the United States. The company’s lead product candidate is CTx-1301 (dexmethylphenidate), which is in Phase 3 clinical trials for the treatment of ADHD in children, adolescents, and adults. It also develops CTx-2103 (buspirone), which is in a formulation stage for the treatment of anxiety. In addition, the company plans to initiate a clinical plan for CTx-1302 (dextroamphetamine) to treat ADHD. Cingulate Inc. was founded in 2012 and is headquartered in Kansas City, Kansas.

Want to learn more about Cingulate Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Cingulate Inc..

Cingulate Inc.’s Stock Price as of Market Close

As of July 31, 2026, 4:00 PM, CST, Cingulate Inc.’s stock price was $4.790.

Cingulate Inc. is up 0.63% from its previous closing price of $4.760.

During the last market session, Cingulate Inc.’s stock traded between $4.635 and $4.840. Currently, there are approximately 9.78 million shares outstanding for Cingulate Inc..

Cingulate Inc.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

Cingulate Inc. Stock Price History

Cingulate Inc.’s (CING) price is currently down 12.43% so far this month.

During the month of July, Cingulate Inc.’s stock price has reached a high of $6.040 and a low of $4.195.

Over the last year, Cingulate Inc. has hit prices as high as $11.890 and as low as $3.160. Year to date, Cingulate Inc.’s stock is up 10.37%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Cingulate Inc. Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of July 31, 2026, there was 1 analyst who downgraded Cingulate Inc.’s stock and 2 analysts who upgraded over the last month.

Additionally, you'll want to evaluate Cingulate Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Cingulate Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Cingulate Inc. (CING) by visiting AAII Stock Evaluator.

Relative Price Strength of Cingulate Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of July 31, 2026, Cingulate Inc. has a weighted four-quarter relative price strength of -2.93%, which translates to a Momentum Score of 43 and is considered to be Average.

Want to learn more about how Cingulate Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Cingulate Inc. Stock Price: Bottom Line

As of July 31, 2026, Cingulate Inc.’s stock price is $4.790, which is up 0.63% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Cingulate Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.